METRONIDAZOLE INJECTION, USP DIN 00870420
Health Canada record
| Active ingredient(s) | METRONIDAZOLE 5 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01XD01 METRONIDAZOLE |
| Original market date | 31-Dec-1990 |
| Current status date | 03-Sep-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Baxter Corporation — licence 100278, currently licensed, last inspection rating C (2026-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METRONIDAZOLE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02248562 | APO-METRONIDAZOLE | APOTEX INC | Capsule | METRONIDAZOLE 500 MG | Marketed |
| 00545066 | APO-METRONIDAZOLE TABLETS | APOTEX INC | Tablet | METRONIDAZOLE 250 MG | Marketed |
| 02470284 | AURO-METRONIDAZOLE | AURO PHARMA INC | Capsule | METRONIDAZOLE 500 MG | Marketed |
| 02499819 | ERADIA | VIRBAC AH, INC. | Suspension | METRONIDAZOLE 125 MG | Marketed |
| 01926829 | FLAGYSTATIN | SANOFI-AVENTIS CANADA INC | Ovule | METRONIDAZOLE 500 MG; NYSTATIN 100000 UNIT | Marketed |
| 02571129 | JAMP METRONIDAZOLE GEL | JAMP PHARMA CORPORATION | Gel | METRONIDAZOLE 0.75 % | Approved |
| 02519755 | M-METRONIDAZOLE | MANTRA PHARMA INC | Capsule | METRONIDAZOLE 500 MG | Marketed |
| 02491370 | MAR-METRONIDAZOLE | MARCAN PHARMACEUTICALS INC | Capsule | METRONIDAZOLE 500 MG | Approved |
| 02092832 | METROGEL 0.75% | GALDERMA CANADA INC. | Gel | METRONIDAZOLE 0.75 % | Marketed |
| 02297809 | METROGEL 1% | GALDERMA CANADA INC. | Gel | METRONIDAZOLE 1 % | Marketed |
| 02518767 | METRONIDAZOLE | JAMP PHARMA CORPORATION | Capsule | METRONIDAZOLE 500 MG | Marketed |
| 02534592 | METRONIDAZOLE | SANIS HEALTH INC | Capsule | METRONIDAZOLE 500 MG | Marketed |
| 02535807 | MINT-METRONIDAZOLE | MINT PHARMACEUTICALS INC | Tablet | METRONIDAZOLE 250 MG | Marketed |
| 02125226 | NIDAGEL | BAUSCH HEALTH, CANADA INC. | Gel | METRONIDAZOLE 0.75 % | Marketed |
| 02156091 | NORITATE | BAUSCH HEALTH, CANADA INC. | Cream | METRONIDAZOLE 1 % | Marketed |
| 00783137 | PMS-METRONIDAZOLE | PHARMASCIENCE INC | Capsule | METRONIDAZOLE 500 MG | Marketed |
| 02564351 | PMS-METRONIDAZOLE GEL | PHARMASCIENCE INC | Gel | METRONIDAZOLE 1 % | Approved |
| 02564343 | PMS-METRONIDAZOLE GEL | PHARMASCIENCE INC | Gel | METRONIDAZOLE 0.75 % | Approved |
| 02567350 | TARO-METRONIDAZOLE GEL | TARO PHARMACEUTICALS INC | Gel | METRONIDAZOLE 1 % | Approved |
| 02567342 | TARO-METRONIDAZOLE GEL | TARO PHARMACEUTICALS INC | Gel | METRONIDAZOLE 0.75 % | Approved |
| 02406489 | APO-METRONIDAZOLE | APOTEX INC | Capsule | METRONIDAZOLE 500 MG | Cancelled Pre Market |
| 02406470 | APO-METRONIDAZOLE | APOTEX INC | Tablet | METRONIDAZOLE 250 MG | Cancelled Pre Market |
| 01926861 | FLAGYL | SANOFI-AVENTIS CANADA INC | Cream | METRONIDAZOLE 10 % | Cancelled Post Market |
| 01926853 | FLAGYL | SANOFI-AVENTIS CANADA INC | Capsule | METRONIDAZOLE 500 MG | Cancelled Pre Market |
| 01926888 | FLAGYL 500 500MG | AVENTIS PHARMA INC | Suppository | METRONIDAZOLE 500 MG | Cancelled Post Market |
| 01926837 | FLAGYSTATIN | AVENTIS PHARMA INC | Suppository | METRONIDAZOLE 500 MG; NYSTATIN 100000 UNIT | Cancelled Post Market |
| 01926845 | FLAGYSTATIN | SANOFI-AVENTIS CANADA INC | Cream | METRONIDAZOLE 500 MG; NYSTATIN 100000 UNIT | Cancelled Post Market |
| 02244405 | FLORAZOLE ER | FERRING INC | Tablet (Extended-Release) | METRONIDAZOLE 750 MG | Cancelled Post Market |
| 02248206 | METROLOTION | GALDERMA CANADA INC. | Lotion | METRONIDAZOLE 0.75 % | Cancelled Post Market |
| 00649074 | METRONIDAZOLE INJECTION USP | PFIZER CANADA ULC | Solution | METRONIDAZOLE 5 MG | Cancelled Post Market |
| 00420409 | METRONIDAZOLE TAB 250MG | PRO DOC LIMITEE | Tablet | METRONIDAZOLE 250 MG | Cancelled Post Market |
| 00021555 | NOVO-NIDAZOL TAB 250MG | NOVOPHARM LIMITED | Tablet | METRONIDAZOLE 250 MG | Cancelled Post Market |
| 00584339 | PMS-METRONIDAZOLE 250MG/TAB | PHARMASCIENCE INC | Tablet | METRONIDAZOLE 250 MG | Cancelled Post Market |
| 02242919 | ROSASOL | GLAXOSMITHKLINE INC | Cream | METRONIDAZOLE 1.0 %; OCTINOXATE 7.5 %; AVOBENZONE 2.0 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 1327 | 2000-03-07 | Supplement to a New Drug Submission (SNDS) | PRODUCT NAME CHANGE FROM FLAGYL |
International API supply for METRONIDAZOLE
3 valid EDQM Certificates of Suitability from 3 holders. 2 active FDA Drug Master Files.
Request a quote for METRONIDAZOLE INJECTION, USP